Back to User profile » Professor Barbro Eriksson
Paper published by Professor Barbro Eriksson:
Original Research
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
Wolin EM, Jarzab B, Eriksson B, Walter T, Toumpanakis C, Morse MA, Tomassetti P, Weber MM, Fogelman DR, Ramage J, Poon D, Gadbaw B, Li J, Pasieka JL, Mahamat A, Swahn F, Newell-Price J, Mansoor W, Öberg K
Drug Design, Development and Therapy 2015, 9:5075-5086
Published Date: 3 September 2015